| 09.00 – 11.00 h |
1st
session: cardiovascular disease in women |
| |
Chairman: Antonio
Cano, Valencia, Spain |
| |
Introduction and objectives |
| |
 |
New methods in the assessment
of cardiovascular risk |
| |
|
|
Endothelial function |
| |
|
|
Non-invasive methods for plaque
assessment |
| |
|
|
Biological markers |
| |
|
Juan Cosín, Valencia, Spain |
| |
|
Female gender and stroke: risk,
outcome and prevention |
| |
|
Blanca Fuentes, Madrid, Spain |
| |
|
Metabolic syndrome in women |
| |
|
Juan Ascaso, Valencia, Spain |
| |
|
General Discussion |
| 11.00 - 11.30 h |
Coffee break |
| 11.30 - 12.00 h |
Inaugural
conference |
| |
The
health of women in mid-life: an emergent challenge
(WHILA Study)
Göran Samsioe, Lund, Sweden |
| |
|
| 12.00 - 13.30 h |
2nd session:
Breast cancer risk. From assessment to risk reduction |
| |
Chairman: Pedro
Acién, Alicante, Spain |
| |
Introduction
and objectives |
| |
|
Risk assessment
and advice in clinical practice |
| |
|
Francisco Palau, Valencia, Spain |
| |
|
Reduction
of risk: drugs and other preventive options |
| |
|
Pedro Acién, Alicante, Spain |
| 13.30 – 15.30 h |
Lunch |
| 15.30 – 19.30 h |
3rd session:
osteoporosis |
| |
Chairman: Javier
Ferrer, Oviedo, Spain |
| |
Introduction
and objectives |
| 15.30 - 17.30 h |
|
Osteopenia:
to treat or not to treat |
| |
|
Göran Samsioe, Lund, Sweden |
| |
|
Prevention
and treatment |
| |
|
|
Activating
the estrogen receptor |
| |
|
|
|
The mechanisms
promoted by the estrogen receptor in bone |
| |
|
|
|
Antonio Cano, Valencia, Spain |
| |
|
|
|
SERMs:
present and future |
| |
|
|
|
Santiago Palacios, Madrid, Spain |
| |
|
|
Bisphosphonates:
which, when, for how long |
| |
|
|
|
Which?.
Profile of bisphosphonates |
| |
|
|
|
|
Evidence
based analysis |
| |
|
|
|
|
Mª Dolores Juliá, Valencia, Spain |
| |
|
|
|
|
Speed of
action |
| |
|
|
|
|
Camil Castelo-Branco, Barcelona, Spain |
| |
|
|
|
When to
choose bisphosphonates? |
| |
|
|
|
Joaquin Calaf, Barcelona, Spain |
| |
|
|
|
Long-term
use of bisphosphonates: facts and caveats |
| |
|
|
|
Javier Ferrer, Oviedo, Spain |
| 17.30 – 18.00 h |
Coffee
break |
| 18.00 - 19. 30 h |
|
Where are
we in bone formation? |
| |
|
Antonio Cano, Valencia, Spain |
| |
|
Calcium
and vitamin D? |
| |
|
Martina Dören, Berlin, Germany |
| |
General
Discussion |
| Friday,
September 23rd, 2005 |
| 09.00 – 13.00 h |
Seminar
on Quality of life |
| |
Chairman: Fernando
Bonilla-Musoles, Valencia, Spain |
| |
Introduction
and objectives |
| 09.00 – 10.30 h |
4th session:
Symptom control |
| |
|
News in
hormonal therapy: Progestins |
| |
|
Manuel Neves e Castro, Lisbon, Portugal |
| |
|
An evidence-based
scrutiny of complementary medicines |
| |
|
|
Cimicifuga
Racemosa |
| |
|
|
Eckehard Liske, Salzgitter, Germany |
| |
|
|
Isoflavones |
| |
|
|
Francisco Quereda, Alicante, Spain |
| |
|
A rational
proposal for long-term users |
| |
|
Manuel Neves e Castro, Lisbon, Portugal |
| 10.30 - 11.00 h |
Coffee
break |
| 11.00 – 13.00 h |
5th session:
Sexual dysfunction |
| |
|
Optimizing
detection and assessment |
| |
|
Sandra Leiblum, Piscataway-New Jersey, USA |
| |
|
Androgens |
| |
|
|
Do androgens
work? |
| |
|
|
In women |
| |
|
|
In men |
| |
|
Sandra Leiblum, Piscataway-New Jersey, USA |
| |
|
Dissecting
the androgen portfolio: tibolone and alternatives |
| |
|
Martina Dören, Berlin, Germany |
| |
General
Discussion |
| 13.00 – 15.00 h |
Lunch |
| 15.00 – 19.00 h |
Seminar:
Pelvic floor and incontinence |
| |
Chairman: Lorenzo
Abad, Murcia, Spain |
| |
Introduction
and objectives |
| 15.00 – 17.00 h |
6th session:
The incontinent woman |
| |
|
Complete
assessment in the office?. Modern options |
| |
|
Manuel Fillol, Castellón, Spain |
| |
|
Initial
management of urinary incontinence |
| |
|
Montserrat Espuña, Barcelona, Spain |
| |
|
A critical
view of the modern sling techniques |
| |
|
Anthony Smith, Manchester, United Kingdom |
| 17.00 – 17.30 h |
Coffe break |
| 17.30 - 19.00 h |
7th session:
Pelvic floor disorders |
| |
|
New meshes
in reconstructive surgery: pros and cons |
| |
|
Justo Callejo, Barcelona, Spain |
| |
|
A critical
view of the surgical options |
| |
|
Lorenzo Abad, Murcia, Spain |
| |
General
Discussion |
